Chronic Smell and Flavor Loss Market Growth, Regional Analysis, Trends and Forecast 2023 to 2033
The global chronic odour and flavour loss treatment market is currently valued at $3146 million in 2023, with a 6.4% CAGR expected. The market is expected to reach $5850.2 million by 2033 as a result of technological advancements in healthcare. The chronic smell and flavour loss market is expected to be driven by rising cases of post-covid flavour loss over the forecast period. The ongoing COVID-19 crisis, as well as the expected success of the sole pipeline candidate, are expected to have an impact on the chronic smell and flavour loss treatment market in the coming years. The development of disease-specific therapies for chronic odour and flavour loss is encouraging for market growth. For example, phosphodiesterase (PDE) inhibitors designed for intranasal administration are present in CYR-064 compositions. The underlying mechanism of all pathologies causing smell and flavour loss is the same. It involves inhibiting the activation of stem cells, which is normally mediated by aden...